Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Sumitomo/Tokyo Uni in aflatoxin control deal

Sumitomo Corporation has signed an exclusive licensing agreement with the University of Tokyo to develop, market, produce and distribute a bacterium-based technology to control aflatoxin production. The bacterium produces a substance that inhibits aflatoxin production without affecting the growth of the fungus that produces aflatoxin, thus avoiding the development of a resistant strain. The University has submitted a patent application for the technology developed by researchers led by Associate Professor Shohei Sakuda. Sumitomo expects to follow up the agreement by bringing in a third partner to commercialise the technology. Aflatoxin contamination leads to losses of some $600 million in the US and $1,300 million in Asia, the company says.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts